ATOPIC DERMATITIS ACROSS THE LIFESPAN: PATHOGENESIS AND THERAPEUTIC HORIZONS
Keywords:
Keywords: To analyze the clinical, genetic, and therapeutic landscape of AD, a systematic narrative synthesis was conducted.Abstract
Atopic dermatitis (AD) is a highly prevalent, chronic inflammatory skin disease that represents a major global public health and socioeconomic burden, affecting up to twenty percent of children and ten percent of adults worldwide. Pathophysiologically, the disease is characterized by a complex, bimodal lifespan trajectory driven by a multifaceted, dynamic interplay of epidermal barrier dysfunction, innate and adaptive immune dysregulation, and microbial dysbiosis. The clinical presentation undergoes distinct age-dependent transitions, progressing from acute, Th17-skewed extensor lesions in infancy to chronic, Th22- and Th1-skewed flexural plaques in adulthood. Furthermore, early-life skin barrier impairment frequently initiates the "atopic march," sequentially predisposing children to food allergies, asthma, and allergic rhinitis, with longitudinal trajectories displaying significant racial and socioeconomic variations.